ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.

Stephen Yip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.